| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT USE IN UNAPPROVED INDICATION | 573 |
| 1 | OFF LABEL USE | 200 |
| 2 | ADAMTS13 ACTIVITY DECREASED | 156 |
| 3 | EPISTAXIS | 129 |
| 4 | PLATELET COUNT DECREASED | 129 |
| 5 | FATIGUE | 111 |
| 6 | CONTUSION | 86 |
| 7 | THROMBOTIC THROMBOCYTOPENIC PURPURA | 81 |
| 8 | HEADACHE | 79 |
| 9 | CONDITION AGGRAVATED | 78 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | ADAMTS13 INHIBITOR SCREEN ASSAY | 3 | 1.0000 |
| 1 | ADAMTS13 ACTIVITY ASSAY | 1 | 1.0000 |
| 2 | ADAMTS13 ACTIVITY ABNORMAL | 72 | 0.8000 |
| 3 | PLACENTAL OEDEMA | 8 | 0.7273 |
| 4 | ADAMTS13 ACTIVITY DECREASED | 156 | 0.6190 |
| 5 | ADAMTS13 ACTIVITY INCREASED | 4 | 0.5000 |
| 6 | POST TRANSFUSION PURPURA | 2 | 0.2500 |
| 7 | BLOOD GLUCAGON DECREASED | 1 | 0.0833 |
| 8 | LYMPHOCYTE PERCENTAGE ABNORMAL | 3 | 0.0448 |
| 9 | RETICULOCYTE PERCENTAGE INCREASED | 2 | 0.0303 |